USPSTF vs specialty societies: Where cancer screening guidelines clash in older adults

By Elizabeth PrattFact-checked by Barbara BekieszPublished March 24, 2026


Key Takeaways
  • Conflicting guidelines (USPSTF vs ACS/NCCN) reflect population-level vs individual-risk framing—don’t default to age cutoffs alone when deciding screening in older adults.

  • Life expectancy >10 years is a practical anchor: Match screening to “time to benefit,” not chronological age.

  • Before ordering: Will results change management, can the patient tolerate treatment, and do benefits outweigh harms? These questions often matter more than guideline alignment.

Industry Buzz

The data available to each of these organizations is the same; the interpretation of screening risks and benefits is what varies.

—Richard Reitherman, MD, PhD

The USPSTF guidelines do not take into account the individual health status of our patients.

—Jessica Kalender-Rich, MD

Cancer screening guidelines in older adults aren’t always simple.

Guidelines from the United States Preventive Services Task Force and specialist societies don’t always match. Various agencies—including the American Cancer Society, the American College of Radiology, the National Comprehensive Cancer Network (NCCN), the American College of Obstetrics and Gynecology, and the American College of Surgeons—publish and promote guidelines that are different usually in terms of age-related categories.

The data available is the same, but the interpretation varies. Do you know the right steps to take in the clinic?

"The most important concept to remember is that some agencies, in particular USPSTF, heavily bias their recommendation based on the cost and inconvenience of testing in the population as opposed to the benefit and risk to an individual woman," Richard Reitherman, MD, PhD, board-certified radiologist and Medical Director of Breast Imaging at MemorialCare Breast Center at Orange Coast Medical Center in Fountain Valley, CA, tells MDLinx.

When recommendations clash

For breast cancer screening recommendations, the USPSTF recommends that all women be screened for breast cancer every other year, beginning at the age of 40 and continuing until the age of 74.[]

Related: What cancer screenings should older adults get?

Guidelines from the American Cancer Society vary slightly, with a yearly screening being optional for women between the ages of 40 to 44. Mammograms are then recommended every year for women aged 45 to 54. For women 55 and older, the Society recommends screening every other year, but notes women may choose to continue with yearly screening.[]

Unlike the USPSTF recommendations, which say that screening can stop at age 74, the American Cancer Society advises continuing the screening, provided that the woman is in good health and is also expected to live at least 10 more years.

“In my opinion,” says Jessica Kalender-Rich, MD, Geriatric Medicine Specialist at The University of Kansas Health System, “the USPSTF guidelines do not take into account the individual health status of our patients. Age is just a number, and while that number may have implications, I want my loved ones to have their decisions made at the individual level rather than the population level. Unfortunately, we do not have a standardized, algorithmic way to individualize patient care. This leads to population-based recommendations that don’t apply to the extremes of functional and medical status.”

When should screening be stopped?

Before each test is ordered, we should be asking ourselves three questions:

  • Do the potential benefits of this test outweigh the potential risks?

  • Would patients be able to tolerate treatment of anything we find?

  • Will the outcomes for this patient change based on the findings of the test?

Life expectancy and benefit to the patient should be the factors that decide when screening stops for older patients, Dr. Kalender-Rich says.

“Screenings for cancer should stop based on a person’s life expectancy and the test’s  potential benefit. As an example, if a particular screening’s time to benefit is 10 years, only someone whose medical and functional status suggests that they have a 10+ years of life expectancy should have that screening,” she adds.

Related: What cancer screenings should older adults get?

SHARE THIS ARTICLE

ADVERTISEMENT